ArticleIJID regions2025
Six recent cases of severe fever with thrombocytopenia syndrome during the 2024 - 2025 in Kochi, Japan: A possible surge and clinical clue for early recognition.
Article in IJID regions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To characterize recent clinical features of severe fever with thrombocytopenia syndrome (SFTS) in an endemic region of Japan, emphasizing the importance of early clinical recognition. Methods: We retrospectively analyzed six consecutive adult patients with SFTS diagnosed at Kochi Health Science Center (Kochi, Japan) between 2024 and June 2025. Diagnosis was confirmed by real-time polymerase chain reaction testing, and viral load was quantified. Patient characteristics, animal exposure history, and laboratory findings were summarized. Results: Symptom onset occurred between March and November. Four patients had no tick bite marks, while three had recent cat exposure. All patients exhibited thrombocytopenia, elevated liver enzymes, and a slight elevation of serum C-reactive protein. Favipiravir was administered in all cases, with five recoveries. One patient developed hemophagocytic syndrome despite a moderate viral load. Conclusions: In endemic and warm-climate regions, SFTS should be suspected year-round. Key clinical features, including cat exposure, thrombocytopenia, and a slight elevation of serum C-reactive protein, may aid early diagnosis even in the absence of tick bite history.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.